[Kaposi sarcoma in AIDS patients. Treatment with a vinblastine-vincristine and molgramostim combination].
Dine
G
G
Bressieux
J M
JM
Penouil
M H
MH
Brahimi
S
S
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000209:etiology; D014747:Vinblastine / Q000008:administration & dosage / Q000627:therapeutic use*; D014750:Vincristine / Q000008:administration & dosage / Q000627:therapeutic use*
D011994:Recombinant Proteins; D014750:Vincristine; D014747:Vinblastine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; C082430:molgramostim
Sarcome de Kaposi chez les patients atteints de SIDA. Traitement par une association vinblastine-vincristine et molgramostime.